Taking a look at one attempt to rein in the EpiPen cost problem

As the finger-pointing and public outrage rages on over EpiPen pricing, Mylan recently announced plans to offer discounts, via coupon, to ease the cost impact. Health economists, however, take issue with this approach, as explained in an article posted by WebMD Health News’ Brenda Goodman. Read more…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s 
 validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.